David Kahn

Publication Details

  • Laparoscopic repair for recurrent abdominal wall hernia after TRAM flap breast reconstruction - Case report of 2 patients ANNALS OF PLASTIC SURGERY Shaw, R. B., Curet, M. J., Kahn, D. M. 2006; 56 (4): 447-450

    Abstract:

    The transverse rectus abdominis musculocutaneous (TRAM) flap is an appealing option for women choosing between various breast reconstructive techniques as it results in an autologous reconstructed breast that is soft and mimics a natural breast. Despite these benefits, there are complications with this procedure, such as pain at the donor site, longer scars, and most frequently the occurrence of abdominal wall hernia or bulge, which has been reported in up to 20%-40% of patients.In this case report, we share our experience with 2 patients who had multiple open hernia repairs, 5 between the 2 of them, after their TRAM flap surgery. Each of these 5 repairs was performed with a Prolene mesh overlay, but not one lasted for more than 6 months. After reviewing our patients' records and our surgical options, we decided to proceed with laparoscopic repair of their recurrent hernias.The patients are now at postoperative follow-up of 12 months and 15 months, with no evidence of recurrence.Laparoscopic surgery has many benefits, such as shorter hospitalization and decreased pain. For our patients, it also resulted in a more beneficial and longer-lasting repair. We believe that this is partly due to the mechanics of the repair, which allows the abdominal contents to buttress the mesh against the abdominal wall. In addition, we believe that this technique reinforces the posterior sheath, which may not be accomplished in an open repair. This is important as most hernias after TRAM flap surgery occur below the arcuate line. From our experience with these 2 patients, we now advocate the use of laparoscopic repair as a treatment option for those who present with recurrent abdominal wall hernia or bulge after their TRAM flap surgery and believe with more experience it will become a first-line treatment.

    View details for DOI 10.1097/01.sap.0000200281.24169.1f

    View details for Web of Science ID 000236376900025

    View details for PubMedID 16557083

Stanford Medicine Resources:

Footer Links: